Related references
Note: Only part of the references are listed.Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient
J. A. Douglass et al.
ALLERGY (2010)
Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma
Philip J. Lowe et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Therapeutic efficacy of omalizumab
Donald MacGlashan
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis
K. Kontou-Fili
ALLERGY (2008)
Treatment of chronic autoimmune urticaria with omalizumab
Allen P. Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms
Niti Puri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Basophil histamine release decreases during omalizumab therapy in allergic asthmatics
Oliver Noga et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2008)
Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab
Mark F. Sands et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Anti-IgE treatment of eosinophil-associated gastrointestinal disorders
Shabnam Foroughi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Successful treatment of cutaneous mastocytosis and Meniere disease with anti-IgE therapy
Frank Siebenhaar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis
Melody C. Carter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Differential release of mast cell mediators and the pathogenesis of inflammation
Theoharis C. Theoharides et al.
IMMUNOLOGICAL REVIEWS (2007)
Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder
Gerhard J. Molderings et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcεRI-aggregation reveals a complex network of genes involved in inflammatory responses
Manikandan Jayapal et al.
BMC GENOMICS (2006)
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis
TB Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Anti-IgE as a mast cell-stabilizing therapeutic agent
TW Chang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils
H Lin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Omalizumab-induced reductions in mast cell FcεRI expression and function
LA Beck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
Share Paper
